Schizoaffective Disorder

• FDA approval · 2010-04-15
  FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc.

• FDA approval · 2009-07-31
  FDA Approved: INVEGA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  FDA approved a supplemental application for INVEGA (paliperidone) submitted by Janssen Pharmaceuticals, Inc.

• FDA approval · 2009-05-27
  FDA Approved: LOXAPINE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for LOXAPINE (loxapine) from Actavis Pharma, Inc., under ANDA072205. This action represents an appro…

• FDA approval · 2009-04-08
  FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

  The FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc. The action confirms regulatory clearance f…

• FDA approval · 2006-10-20
  FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-09-20
  FDA Approved: SEROQUEL — Supplemental Application (H2-Pharma, LLC)

  The FDA approved a supplemental application for SEROQUEL (quetiapine) filed by H2-Pharma, LLC.